APOB and obesity due to melanocortin 4 receptor deficiency: Obesity is known to increase the chances of developing dyslipidemia, characterized by elevated plasma triglycerides, reduced high-density lipoprotein (HDL) cholesterol, and elevated apoB concentration (57).